Miriam J. Paramore's most recent trade in OptimizeRx Corp was a trade of 15,000 Common Stock Pursuant to 10B5-1 Plan done at an average price of $95.5 . Disclosure was reported to the exchange on Nov. 2, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| OptimizeRx Corp | Miriam J. Paramore | PRES. & CHIEF STRATEGY OFFICER | Sale of securities on an exchange or to another person at price $ 95.45 per share. | 02 Nov 2021 | 15,000 | 74,607 (0%) | 0% | 95.5 | 1,431,750 | Common Stock Pursuant to 10B5-1 Plan |
| OptimizeRx Corp | Miriam J. Paramore | PRES. & CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2021 | 15,000 | 94,318 | - | - | Stock Option | |
| OptimizeRx Corp | Miriam J. Paramore | PRES. & CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.51 per share. | 02 Nov 2021 | 15,000 | 89,607 (0%) | 0% | 7.5 | 112,650 | Common Stock |